Related Experiment Videos
Maternal phenylketonuria: a metabolic teratogen
Teratology
|March 1, 1996
Summary
Maternal phenylketonuria (PKU) can cause severe birth defects. Strict dietary management of phenylalanine levels before and during pregnancy is crucial for preventing these adverse outcomes in offspring.
Area of Science:
- Reproductive Medicine
- Metabolic Disorders
- Teratology
Background:
- Maternal phenylketonuria (PKU) syndrome describes pregnancy complications arising from the mother's PKU.
- Untreated PKU in mothers leads to high rates of offspring abnormalities like microcephaly and intellectual disability.
Purpose of the Study:
- To outline the teratogenic effects of maternal PKU.
- To discuss the dose-response relationship between phenylalanine levels and fetal abnormalities.
- To review current treatment and management strategies for maternal PKU.
Main Methods:
- Review of existing literature on maternal PKU and its effects.
- Analysis of dose-response relationships between maternal phenylalanine levels and offspring outcomes.
- Discussion of treatment modalities, including dietary management and psychosocial support.
Main Results:
- High incidence of microcephaly (75-90%) and mental retardation in offspring of untreated classic PKU pregnancies (>1,200 microM phenylalanine).
- Congenital heart disease observed in approximately 15% of offspring.
- Lower phenylalanine levels correlate with reduced frequency of abnormalities, indicating a dose-response effect.
Conclusions:
- Maternal PKU poses significant teratogenic risks to the fetus.
- Early and strict dietary control of phenylalanine is essential for successful pregnancy outcomes.
- Psychosocial support is vital for patient compliance with treatment regimens.